Skip to main content

Medications for Attention Deficit Hyperactivity Disorder & Cardiomyopathy and Heart Failure

    Basic Details
    Last Updated
    Wednesday, December 29, 2021
    Original Posting Date
    Health Outcome(s)
    heart failure or cardiomyopathy
    Drug and Outcome Analysis
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    Regulatory Determination / Use

    Follow up investigation of case reports of cardiac events after long term stimulant use. FDA decided that no action is necessary at this time, based on available information.